GSK asthma app wins health technology award
A GlaxoSmithKline mobile app that helps asthma patients better understand their condition and how to manage it was one of six winners of the AXA PPP Health Tech & You Awards.
MyAsthma, which was developed with UK agency The Earthworks, can track medication use and asthma attacks, and use location, weather and air quality data to find out what triggers asthma. patient’s asthma.
An industry first, GSK’s app is the first in the pharmaceutical industry to be approved as a Class 1 medical device and CE marked.
Its co-winners at the awards included software that turns physiotherapy into video games and a collection of clothing that heightens or dampens the senses to help people with autism.
Also recognized were the Affinity connected device allowing people with cancer to monitor their blood counts at home, the uMotif platform – which captures high-quality patient health data through the digital tools they use, and the network social for health HealthUnlocked.
Gordon Henderson, Director of Marketing and Innovation at AXA PPP Healthcare, said: “The awards recognize and celebrate the best personal health technology innovations for the benefit of consumers and our members to live and maintain a lifestyle. healthy.
“This year’s winners and runners-up show the emergence of artificial intelligence, interactive wearables, gamification and personal medical testing – health technology that would have seemed far ahead of the time when AXA PPP Healthcare founded the Health Tech & You program in 2014.”
The 2017 winners were announced at the Design Museum in London last week, where they will be on display as part of a free Health Tech & You exhibition that will run until May 8.